drug
as of 2026-07-01SPG302
at a glance
Synthesized from structured facts only — each point cited above.
Mechanism & identity
Modality
small molecule
Indications
Investigational (via trials)
Trials
1
Study of SPG302 in Adults With Schizophrenia
NCT06442462Phase 2Active Not Recruiting
KOLs & investigators
1
David P Walling, PhDKOL score 17
Facts & assertions
0 sourced
No assertions recorded for this entity.
relationships
The graph out of here